BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 23108547)

  • 21. Fatty acid amide hydrolase inhibition normalises bladder function and reduces pain through normalising the anandamide/palmitoylethanolamine ratio in the inflamed bladder of rats.
    Charrua A; Matos R; Oliveira R; Marczylo T; Nagy I; Cruz F
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Feb; 393(2):263-272. PubMed ID: 31522241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption.
    Rossi F; Siniscalco D; Luongo L; De Petrocellis L; Bellini G; Petrosino S; Torella M; Santoro C; Nobili B; Perrotta S; Di Marzo V; Maione S
    Bone; 2009 Mar; 44(3):476-84. PubMed ID: 19059369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors.
    Maione S; De Petrocellis L; de Novellis V; Moriello AS; Petrosino S; Palazzo E; Rossi FS; Woodward DF; Di Marzo V
    Br J Pharmacol; 2007 Mar; 150(6):766-81. PubMed ID: 17279090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors.
    Morgese MG; Cassano T; Cuomo V; Giuffrida A
    Exp Neurol; 2007 Nov; 208(1):110-9. PubMed ID: 17900568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of FAAH confers increased stem cell migration via PPARα.
    Wollank Y; Ramer R; Ivanov I; Salamon A; Peters K; Hinz B
    J Lipid Res; 2015 Oct; 56(10):1947-60. PubMed ID: 26263913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
    Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR
    J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase.
    Carey LM; Slivicki RA; Leishman E; Cornett B; Mackie K; Bradshaw H; Hohmann AG
    Mol Pain; 2016; 12():. PubMed ID: 27178246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Untapped endocannabinoid pharmacological targets: Pipe dream or pipeline?
    Wilkerson JL; Bilbrey JA; Felix JS; Makriyannis A; McMahon LR
    Pharmacol Biochem Behav; 2021 Jul; 206():173192. PubMed ID: 33932409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
    Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
    Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The endocannabinoid system is modulated in response to spinal cord injury in rats.
    Garcia-Ovejero D; Arevalo-Martin A; Petrosino S; Docagne F; Hagen C; Bisogno T; Watanabe M; Guaza C; Di Marzo V; Molina-Holgado E
    Neurobiol Dis; 2009 Jan; 33(1):57-71. PubMed ID: 18930143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain.
    Guasti L; Richardson D; Jhaveri M; Eldeeb K; Barrett D; Elphick MR; Alexander SP; Kendall D; Michael GJ; Chapman V
    Mol Pain; 2009 Jul; 5():35. PubMed ID: 19570201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA; Kaiser N; Monory K; Lutz B
    Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in the expression of endocannabinoid system components in an experimental model of chemotherapy-induced peripheral neuropathic pain: Evaluation of sex-related differences.
    Noya-Riobó MV; Miguel CÁ; Soriano DB; Brumovsky PR; Villar MJ; Coronel MF
    Exp Neurol; 2023 Jan; 359():114232. PubMed ID: 36179876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticonvulsive effects of endocannabinoids; an investigation to determine the role of regulatory components of endocannabinoid metabolism in the Pentylenetetrazol induced tonic- clonic seizures.
    Zareie P; Sadegh M; Palizvan MR; Moradi-Chameh H
    Metab Brain Dis; 2018 Jun; 33(3):939-948. PubMed ID: 29504066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spinal anandamide produces analgesia in neuropathic rats: possible CB(1)- and TRPV1-mediated mechanisms.
    Starowicz K; Makuch W; Osikowicz M; Piscitelli F; Petrosino S; Di Marzo V; Przewlocka B
    Neuropharmacology; 2012 Mar; 62(4):1746-55. PubMed ID: 22178705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey.
    Kawahara H; Drew GM; Christie MJ; Vaughan CW
    Br J Pharmacol; 2011 Jul; 163(6):1214-22. PubMed ID: 21175570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The endocannabinoid system: Overview of an emerging multi-faceted therapeutic target.
    Chanda D; Neumann D; Glatz JFC
    Prostaglandins Leukot Essent Fatty Acids; 2019 Jan; 140():51-56. PubMed ID: 30553404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anandamide in primary sensory neurons: too much of a good thing?
    Sousa-Valente J; Varga A; Ananthan K; Khajuria A; Nagy I
    Eur J Neurosci; 2014 Feb; 39(3):409-18. PubMed ID: 24494681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of chronic exercise on the endocannabinoid system in Wistar rats with high-fat diet-induced obesity.
    Gamelin FX; Aucouturier J; Iannotti FA; Piscitelli F; Mazzarella E; Aveta T; Leriche M; Dupont E; Cieniewski-Bernard C; Montel V; Bastide B; Di Marzo V; Heyman E
    J Physiol Biochem; 2016 Jun; 72(2):183-99. PubMed ID: 26880264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
    Forget B; Guranda M; Gamaleddin I; Goldberg SR; Le Foll B
    Psychopharmacology (Berl); 2016 May; 233(10):1823-8. PubMed ID: 26864774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.